Dynavax Technologies Corporation (NASDAQ:DVAX), one of our swing trades, is doing great, jumping another 1.75, or 8%, to 23.25, on 3.6 million shares traded on Monday. After the pop, explosive move, and wedge, we gave you a buy on it. This stock has gone from 15.00 to 23.00, and change, and it looks like it can go higher. My next target is in the 28-9 zone. It has 4.5 days to cover .
ImmunoGen Inc (NASDAQ:IMGN) is one of our swing trades that has worked beautifully this year. It stair-stepped up beautifully, formed a recent falling wedge, popped out of it, and has been up every day, or seven days, since then. It’s now up against resistance. On Monday, it was up 27 cents, or 3.53%, to 7.92, on 4 million shares traded. It pulled back enough to close under 8.00. We’ll just have to keep an eye on it. Resistance is at 8.84. If it gets through that, I’m looking for 9 1/2, and then 12.00 as the next targets.
Swing trade Sangamo Therapeutics Inc (NASDAQ:SGMO) broke out on Friday, followed through on Monday with a nice pop of 1.20, or 8%, to 16.20, on 2.4 million shares traded. I like the action. I like the look of it. Lateral resistance is at 20.00. That’s also the top of the channel. I’m looking for a move to the 19-20 zone.
Sarepta Therapeutics Inc (NASDAQ:SRPT), one of our swing trades, is working well, jumping 4.19, or 9%, to 49.55, on 4.55 million shares traded on Monday. It crossed the consolidation zone, and closed at the high for the day going away. That’s the best volume on an up-day in a month. It looks to me like it’s headed for 56.00. It has five days to cover .
On the long side, stocks included Abeona Therapeutics Inc (NASDAQ:ABEO),Arbutus Biopharma Corp (NASDAQ:ABUS), AcelRx Pharmaceuticals, Inc. (ACRX), Bristol-Myers Squibb Company (NYSE:BMY), Dicerna Pharmaceuticals Inc (NASDAQ:DRNA), Dynavax Technologies Corporation (DVAX), Endocyte, Inc. (ECYT), General Motors Company (NYSE:GM), Helios and Matheson Analytics Inc. (HMNY), ImmunoGen, Inc. (IMGN), Inovalon Holdings, Inc. (INOV), Impax Laboratories Inc (NASDAQ:IPXL), Kandi Technologies Group, Inc. (KNDI), Kronos Worldwide, Inc. (KRO), Pieris Pharmaceuticals, Inc. (PIRS), uniQure N.V. (QURE), Rigel Pharmaceuticals, Inc. (RIGL), Seattle Genetics, Inc. (SGEN), Sangamo Therapeutics, Inc. (SGMO), Spectrum Pharmaceuticals, Inc. (SPPI), Square, Inc. (NYSE:SQ), Sarepta Therapeutics, Inc. (SRPT), VirnetX Holding Corp (VHC), Voyager Therapeutics, Inc. (VYGR), and Zogenix Inc (NASDAQ:ZGNX).